14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
NPCT vs SLSN: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Solesence, Inc. (SLSN) is the stronger overall head-to-head candidate over Nuveen Core Plus Impact Fund (NPCT) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). NPCT carries a Unified Composite Score of 32.9/100 (SELL) at $8.68 (N/M Forward P/E, N/A operating margin), whereas SLSN carries 32.4/100 (SELL) at $1.41 (11.4x Forward P/E, 4.5% operating margin).
Defensive Composite Rating Caution: Although SLSN compares more favorably head-to-head, both NPCT (32.9/100 SELL) and SLSN (32.4/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
Technical & Structure Timing Caution: NPCT is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.2); meanwhile SLSN trades in a Markup technical trend (CONSOLIDATION options phase, RSI 65.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NPCT vs SLSN. Trailing 12-month operating profitability (NPCT N/A vs SLSN 4.5%) and valuation multiples (NPCT N/M vs SLSN 11.4x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Household & Personal Products value chain with $104.6M market capitalization and 4.5% operating margin.
OpEx & R&D Reinvestment25.6% of Rev ($16M)
90D Engineering Disclosures0 Published
Investor FAQ NPCT vs SLSN Key Questions & Quantitative Answers
As of Nov 20, 2026, Solesence, Inc. (SLSN) is the stronger overall head-to-head candidate over Nuveen Core Plus Impact Fund (NPCT) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). NPCT carries a Unified Composite Score of 32.9/100 (SELL) at $8.68 (N/M Forward P/E, N/A operating margin), whereas SLSN carries 32.4/100 (SELL) at $1.41 (11.4x Forward P/E, 4.5% operating margin). Defensive Composite Rating Caution: Although SLSN compares more favorably head-to-head, both NPCT (32.9/100 SELL) and SLSN (32.4/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: NPCT is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.2); meanwhile SLSN trades in a Markup technical trend (CONSOLIDATION options phase, RSI 65.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
SLSN leads the Growth & Scale pillar: NPCT posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with SLSN at +38.1% YoY revenue growth and -93.5% YoY earnings growth on $61M TTM revenue (30.1% gross margin, 4.5% operating margin). On trailing 12-month operating scale, NPCT generates N/A in USD-normalized revenue versus $61M for SLSN. In operating R&D and SG&A reinvestment, NPCT deploys N/A (0 90-day corporate R&D disclosures) versus 25.6% of Rev ($16M) (0 disclosures) for SLSN.
SLSN screens cheaper on headline valuation multiples. NPCT trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas SLSN trades at 11.4x Forward P/E, 49.3x Trailing P/E, N/M PEG, and 2.1x EV/Revenue (-1.4% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against NPCT (N/A ROE) versus SLSN (10.7% ROE) capital efficiency.
In options market volatility and institutional positioning, NPCT carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.36β · 13% Vol realized risk). By comparison, SLSN carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (1.49β · 238% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.